Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Garnier

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Molecular Pharmacology|January 17, 2014
The novel arsenical darinaparsin is transported by cystine importing systemsNicolas Garnier, Geneviève G J Redstone, Michael S Dahabieh, et al.
Cancer Research Communications|November 27, 2023
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and RadioresistanceWilliam Echavidre, Jérôme Durivault, Célia Gotorbe, et al.
Human Mutation|November 19, 2009
SM2PH-db: an interactive system for the integrated analysis of phenotypic consequences of missense mutations in proteins involved in human genetic diseasesAnne Friedrich, Nicolas Garnier, Nicolas Gagnière, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via FerroptosisCélia Gotorbe, Fabien Segui, William Echavidre, et al.
Frontiers in Pharmacology|February 15, 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.
Orphanet Journal of Rare Diseases|May 15, 2025
TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care projectChristina Saier, Stefaan Sansen, Joanne Berghout, et al.
Nucleic Acids Research|December 5, 2006
euHCVdb: the European hepatitis C virus databaseChristophe Combet, Nicolas Garnier, Céline Charavay, et al.
BMJ Open|April 20, 2024
Patient preferences in genetic newborn screening for rare diseases: study protocolSylvia Martin, Emanuele Angolini, Jennifer Audi, et al.
Orphanet Journal of Rare Diseases|January 8, 2026
Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022Sylvia Martin, Gergana Kyosovska-Peshtenska, Jennifer Audi, et al.
Plos One|November 22, 2023
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in EuropeNicolas Garnier, Joanne Berghout, Aldona Zygmunt, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Molecular Pharmacology|January 17, 2014
The novel arsenical darinaparsin is transported by cystine importing systemsNicolas Garnier, Geneviève G J Redstone, Michael S Dahabieh, et al.
Cancer Research Communications|November 27, 2023
Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and RadioresistanceWilliam Echavidre, Jérôme Durivault, Célia Gotorbe, et al.
Human Mutation|November 19, 2009
SM2PH-db: an interactive system for the integrated analysis of phenotypic consequences of missense mutations in proteins involved in human genetic diseasesAnne Friedrich, Nicolas Garnier, Nicolas Gagnière, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via FerroptosisCélia Gotorbe, Fabien Segui, William Echavidre, et al.
Frontiers in Pharmacology|February 15, 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.
Orphanet Journal of Rare Diseases|May 15, 2025
TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care projectChristina Saier, Stefaan Sansen, Joanne Berghout, et al.
Nucleic Acids Research|December 5, 2006
euHCVdb: the European hepatitis C virus databaseChristophe Combet, Nicolas Garnier, Céline Charavay, et al.
BMJ Open|April 20, 2024
Patient preferences in genetic newborn screening for rare diseases: study protocolSylvia Martin, Emanuele Angolini, Jennifer Audi, et al.
Orphanet Journal of Rare Diseases|January 8, 2026
Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022Sylvia Martin, Gergana Kyosovska-Peshtenska, Jennifer Audi, et al.
Plos One|November 22, 2023
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in EuropeNicolas Garnier, Joanne Berghout, Aldona Zygmunt, et al.
Pageof 4